Qube Research & Technologies (QRT)’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-554,350
| Closed | -$13.8M | – | 3673 |
|
|
2026
Q2 | $13.8M | Buy |
554,350
+424,757
| +328% | +$9.9M | 0.01% | 1100 |
|
|
2026
Q1 | $1.82M | Sell |
129,593
-573,322
| -82% | -$7.72M | ﹤0.01% | 2232 |
|
|
2025
Q4 | $7.89M | Sell |
702,915
-24,923
| -3% | -$285K | 0.01% | 1496 |
|
|
2025
Q3 | $8.41M | Buy |
727,838
+102,429
| +16% | +$1.2M | 0.01% | 1431 |
|
|
2025
Q2 | $7.66M | Buy |
625,409
+153,547
| +33% | +$1.93M | 0.01% | 1461 |
|
|
2025
Q1 | $6.76M | Buy |
471,862
+360,071
| +322% | +$5.62M | 0.01% | 1375 |
|
|
2024
Q4 | $1.78M | Buy |
+111,791
| New | +$2.21M | ﹤0.01% | 1928 |
|
|
2024
Q3 | – | Sell |
-38,002
| Closed | -$757K | – | 3306 |
|
|
2024
Q2 | $757K | Sell |
38,002
-65,418
| -63% | -$1.27M | ﹤0.01% | 2000 |
|
|
2024
Q1 | $2.06M | Sell |
103,420
-16
| -0% | -$309 | ﹤0.01% | 1736 |
|
|
2023
Q4 | $2.32M | Buy |
103,436
+30,203
| +41% | +$623K | ﹤0.01% | 1452 |
|
|
2023
Q3 | $1.48M | Buy |
73,233
+57,040
| +352% | +$1.29M | ﹤0.01% | 1543 |
|
|
2023
Q2 | $414K | Buy |
+16,193
| New | +$426K | ﹤0.01% | 1566 |
|
|
2022
Q4 | – | Sell |
-18,032
| Closed | -$393K | – | 2459 |
|
|
2022
Q3 | $393K | Sell |
18,032
-1,168
| -6% | -$30.5K | ﹤0.01% | 1548 |
|
|
2022
Q2 | $525K | Sell |
19,200
-9,408
| -33% | -$270K | ﹤0.01% | 1388 |
|
|
2022
Q1 | $958K | Buy |
+28,608
| New | +$921K | 0.01% | 1196 |
|
|
2021
Q4 | – | Sell |
-8,899
| Closed | -$278K | – | 2519 |
|
|
2021
Q3 | $278K | Sell |
8,899
-7,126
| -44% | -$242K | ﹤0.01% | 1517 |
|
|
2021
Q2 | $583K | Buy |
16,025
+6,898
| +76% | +$285K | 0.01% | 1203 |
|
|
2021
Q1 | $399K | Buy |
9,127
+4,586
| +101% | +$215K | 0.01% | 1309 |
|
|
2020
Q4 | $208K | Buy |
+4,541
| New | +$189K | ﹤0.01% | 1518 |
|
|
2018
Q4 | – | Sell |
-1,749
| Closed | -$120K | – | 336 |
|
|
2018
Q3 | $120K | Buy |
1,749
+1,575
| +905% | +$101K | 0.02% | 697 |
|
|
2018
Q2 | $10K | Buy |
+174
| New | +$9.19K | 0.01% | 758 |
|
Other funds holding AVNS
Qube Research & Technologies (QRT)'s AVNS Position: Q3 2026 in Review
Qube Research & Technologies (QRT) sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 554,350 shares — an estimated $13.8M sold.
Qube Research & Technologies (QRT) first reported a position in AVNS in Q2 2018 and held it in 21 quarters. The position peaked at $13.8M in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.
- Qube Research & Technologies (QRT) reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 554,350 Avanos Medical shares in Q3 2026, an estimated $13.8M.
- Qube Research & Technologies (QRT) first reported a position in Avanos Medical in Q2 2018 and held it in 21 quarters.
- Qube Research & Technologies (QRT)'s Avanos Medical position peaked at $13.8M in Q2 2026.
- 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.